CNBC (2/27, LaVito) reports FDA Commissioner Scott Gottlieb, M.D., told the House Appropriations Committee on Wednesday that the agency “will hold its first public hearings on CBD in April as the agency weighs rules allowing companies to add the popular cannabis-based compound to food.” He said, “We’re deeply focused on this. We have taken on hard challenges before.” Dr. Gottlieb stated he heard Congress “loud and clear” when it legalized hemp products, including CBD, in December. The agency will begin its rulemarking process with the public hearing, but Dr. Gottlieb warned the committee that it will not be a “straightforward” process.
Disclaimer: The American Medical Marijuana Physicians Association does not publish membership information. Our goal is to ensure that community physicians have the tools and resources they need to safely and effectively recommend medical marijuana as a last resort alternative treatment. Physicians should utilize this alternative recommendation based on evidence when available and always educate the patient on potential risks and other treatment options. The American Medical Marijuana Physicians Association supports the need for more research into cannabinoid medicine as more high quality studies are needed. By accessing any page on this site you agree to the Site Terms and Conditions of Use.